ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

October 17, 2014

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992